These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 27552669)

  • 1. Safety and PK/PD correlation of TV-1106, a recombinant fused human albumin-growth hormone, following repeat dose administration to monkeys.
    Ashkenazi N; Rosenstock M; Hallak H; Bassan M; Rasamoelisolo M; Leuschner J; Shinar D
    Growth Horm IGF Res; 2016; 30-31():16-21. PubMed ID: 27552669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the Pharmacokinetics, Pharmacodynamics, and Safety of Single Doses of TV-1106, a Long-Acting Growth Hormone, in Healthy Japanese and Caucasian Subjects.
    Cohen-Barak O; Barkay H; Rasamoelisolo M; Butler K; Yamada K; Bassan M; Yoon E; Spiegelstein O
    Clin Pharmacol Drug Dev; 2017 Jul; 6(4):331-342. PubMed ID: 27489211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonclinical pharmacokinetic and pharmacodynamic characterisation of somapacitan: A reversible non-covalent albumin-binding growth hormone.
    Thygesen P; Andersen HS; Behrens C; Fels JJ; Nørskov-Lauritsen L; Rischel C; Johansen NL
    Growth Horm IGF Res; 2017 Aug; 35():8-16. PubMed ID: 28595133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, pharmacokinetic and pharmacodynamic properties of TV-1106, a long-acting GH treatment for GH deficiency.
    Cohen-Barak O; Sakov A; Rasamoelisolo M; Bassan M; Brown K; Mendzelevski B; Spiegelstein O
    Eur J Endocrinol; 2015 Nov; 173(5):541-51. PubMed ID: 26286586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of once-weekly administration of JR-142, a long-acting albumin-fused human growth hormone: A rondemized, placebo-controlled phase 1 study.
    Owada Y; Okazaki M; Ikeda T; Yamamoto R; Minami K; Takahashi K; Hirato T; Mita Y; Yamamoto T; Tanizawa K; Sonoda H; Sato Y
    Growth Horm IGF Res; 2022 Dec; 67():101500. PubMed ID: 36113378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reversible albumin-binding growth hormone derivative is well tolerated and possesses a potential once-weekly treatment profile.
    Rasmussen MH; Olsen MW; Alifrangis L; Klim S; Suntum M
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1819-29. PubMed ID: 25013997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albutropin: a growth hormone-albumin fusion with improved pharmacokinetics and pharmacodynamics in rats and monkeys.
    Osborn BL; Sekut L; Corcoran M; Poortman C; Sturm B; Chen G; Mather D; Lin HL; Parry TJ
    Eur J Pharmacol; 2002 Dec; 456(1-3):149-58. PubMed ID: 12450581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pegylated long-acting human growth hormone is well-tolerated in healthy subjects and possesses a potential once-weekly pharmacokinetic and pharmacodynamic treatment profile.
    Rasmussen MH; Bysted BV; Anderson TW; Klitgaard T; Madsen J
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3411-7. PubMed ID: 20427496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new sustained-release preparation of human growth hormone and its pharmacokinetic, pharmacodynamic and safety profile.
    Jostel A; Mukherjee A; Alenfall J; Smethurst L; Shalet SM
    Clin Endocrinol (Oxf); 2005 May; 62(5):623-7. PubMed ID: 15853836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible Albumin-Binding GH Possesses a Potential Once-Weekly Treatment Profile in Adult Growth Hormone Deficiency.
    Rasmussen MH; Janukonyté J; Klose M; Marina D; Tanvig M; Nielsen LF; Höybye C; Andersen M; Feldt-Rasmussen U; Christiansen JS
    J Clin Endocrinol Metab; 2016 Mar; 101(3):988-98. PubMed ID: 26727076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro and in Vivo Characterization of MOD-4023, a Long-Acting Carboxy-Terminal Peptide (CTP)-Modified Human Growth Hormone.
    Hershkovitz O; Bar-Ilan A; Guy R; Felikman Y; Moschcovich L; Hwa V; Rosenfeld RG; Fima E; Hart G
    Mol Pharm; 2016 Feb; 13(2):631-9. PubMed ID: 26713839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetic and pharmacodynamic evaluation between a new biosimilar and reference recombinant human growth hormone.
    Toffoletto O; Afiune J; Thiemann JE; Khandave SS; Patel S; Rodrigues DG
    Growth Horm IGF Res; 2016; 30-31():31-36. PubMed ID: 27657985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, Pharmacodynamics, and Safety of a Long-Acting Human Growth Hormone (MOD-4023) in Healthy Japanese and Caucasian Adults.
    Kramer WG; Jaron-Mendelson M; Koren R; Hershkovitz O; Hart G
    Clin Pharmacol Drug Dev; 2018 Jun; 7(5):554-563. PubMed ID: 29136343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and cytokine-mediated effects of albumin-fused growth hormone, TV-1106, on CYP enzyme expression in human hepatocytes in vitro.
    Czerwiński M; Amunom I; Piryatinsky V; Hallak H; Sahly Y; Bar-Ilan O; Bolliger P; Bassan M
    Pharmacol Res Perspect; 2018 Jun; 6(3):e00397. PubMed ID: 29721322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A long-acting pegylated recombinant human growth hormone (Jintrolong
    Guan Y; He F; Wu J; Zhao L; Wang X; Huang L; Zeng G; Ren B; Chen J; Liao X; Ma Z; Chen X; Zhong G; Huang M; Zhao X
    J Clin Pharm Ther; 2018 Oct; 43(5):640-646. PubMed ID: 29959799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term effects of growth hormone and insulin-like growth factor I on cancellous bone in rhesus macaque monkeys.
    Sass DA; Jerome CP; Bowman AR; Bennett-Cain A; Ginn TA; LeRoith D; Epstein S
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1202-9. PubMed ID: 9100597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of growth hormone and nandrolone decanoate alters mRNA expression of the GABAB receptor subunits as well as of the GH receptor, IGF-1, and IGF-2 in rat brain.
    Grönbladh A; Johansson J; Nyberg F; Hallberg M
    Growth Horm IGF Res; 2014; 24(2-3):60-6. PubMed ID: 24480470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacokinetic/pharmacodynamic model for recombinant human growth hormone effects on induction of insulin-like growth factor I in monkeys.
    Sun YN; Lee HJ; Almon RR; Jusko WJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1523-32. PubMed ID: 10336548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency.
    Moore WV; Nguyen HJ; Kletter GB; Miller BS; Rogers D; Ng D; Moore JA; Humphriss E; Cleland JL; Bright GM
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1091-7. PubMed ID: 26672637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.